Therefore, considering the role of HDAC6 in hypoxia-induced metastatic invasion to regional lymphatics, the therapeutic targeting of HDAC6 may have important therapeutic implications for the treatment of metastatic disease [128,129]. The gene discussed is HDAC6; the disease is metastatic neoplasm.